Pruss M, Cieslik J, Torok J, Dobrowolski J, Neubacher M, Helbig M
Arch Gynecol Obstet. 2025; .
PMID: 39912929
DOI: 10.1007/s00404-024-07920-5.
Deckwirth V, Hundi S, Hytonen M, Hannula S, Ellonen P, Bjorkenheim P
BMC Cancer. 2024; 24(1):1524.
PMID: 39696035
PMC: 11657561.
DOI: 10.1186/s12885-024-13239-w.
Amin M, Abdelmohsen U, Samra Y
Nutr Metab (Lond). 2024; 21(1):73.
PMID: 39272080
PMC: 11396339.
DOI: 10.1186/s12986-024-00846-4.
Lao S, Chen Z, Wang W, Zheng Y, Xiong S, He P
NPJ Precis Oncol. 2024; 8(1):164.
PMID: 39080406
PMC: 11289302.
DOI: 10.1038/s41698-024-00639-1.
Ge I, Berner K, Mathis M, Hensgen C, Mayer S, Erbes T
Cancers (Basel). 2024; 16(9).
PMID: 38730711
PMC: 11083990.
DOI: 10.3390/cancers16091760.
Robot-assisted biopsy sampling for online Raman spectroscopy cancer confirmation in the operating room.
Grajales D, Le W, Tran T, David S, Dallaire F, Ember K
Int J Comput Assist Radiol Surg. 2024; 19(6):1103-1111.
PMID: 38573566
DOI: 10.1007/s11548-024-03100-7.
Intertumoral heterogeneity of bifocal breast cancer: a morphological and molecular study.
Finsterbusch K, van Diest P, Focke C
Breast Cancer Res Treat. 2024; 205(2):413-421.
PMID: 38453779
DOI: 10.1007/s10549-024-07281-2.
Comparison between F-FDG PET/CT and diffusion-weighted imaging in detection of invasive ductal breast carcinoma.
Ozen A, Sayin T, Kandemir O, Ekmekcioglu O, Altinay S, Bastug E
Asia Ocean J Nucl Med Biol. 2024; 12(1):11-20.
PMID: 38164229
PMC: 10757063.
DOI: 10.22038/AOJNMB.2023.70534.1493.
A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer.
Amgad M, Hodge J, Elsebaie M, Bodelon C, Puvanesarajah S, Gutman D
Nat Med. 2023; 30(1):85-97.
PMID: 38012314
DOI: 10.1038/s41591-023-02643-7.
In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer.
Asberger J, Berner K, Bicker A, Metz M, Jager M, Weiss D
Biomedicines. 2023; 11(10).
PMID: 37893081
PMC: 10604872.
DOI: 10.3390/biomedicines11102705.
Routine Use of a Standardized Mastectomy Diagram by Surgeons Improves Accuracy and Timeliness of the Final Pathological Report.
Seto A, Pass A, Babkowski R, Volpicelli E, Cheng Z, Pass H
Ann Surg Oncol. 2023; 30(12):7124-7130.
PMID: 37598118
PMC: 10562264.
DOI: 10.1245/s10434-023-14179-8.
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.
Litton J, Regan M, Pusztai L, Rugo H, Tolaney S, Garrett-Mayer E
J Clin Oncol. 2023; 41(27):4433-4442.
PMID: 37433103
PMC: 10522109.
DOI: 10.1200/JCO.23.00435.
Dendritic Cell Subpopulations Are Associated with Morphological Features of Breast Ductal Carcinoma In Situ.
Szpor J, Streb J, Glajcar A, Streb-Smolen A, Lazarczyk A, Korta P
Int J Mol Sci. 2023; 24(12).
PMID: 37373062
PMC: 10298341.
DOI: 10.3390/ijms24129918.
Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma.
Liu L, Lin H, Shen G, Liu Y, Qin X, Yuan Y
BMC Cancer. 2023; 23(1):370.
PMID: 37087442
PMC: 10122816.
DOI: 10.1186/s12885-023-10858-7.
Updates on Lymphovascular Invasion in Breast Cancer.
Kuhn E, Gambini D, Despini L, Asnaghi D, Runza L, Ferrero S
Biomedicines. 2023; 11(3).
PMID: 36979946
PMC: 10046167.
DOI: 10.3390/biomedicines11030968.
Neoductgenesis in Ductal Carcinoma In Situ Coexists with Morphological Abnormalities Characteristic for More Aggressive Tumor Biology.
Lazarczyk A, Streb J, Halubiec P, Streb-Smolen A, Jach R, Hodorowicz-Zaniewska D
Diagnostics (Basel). 2023; 13(4).
PMID: 36832275
PMC: 9954835.
DOI: 10.3390/diagnostics13040787.
Automated breast ultrasound (ABUS) for intraoperative margin control on surgical specimens in breast conserving surgery.
Hatzipanagiotou M, Huber D, Thede E, Scheiter A, Fernandez-Pacheco M, Hetterich M
Arch Gynecol Obstet. 2022; 307(6):1949-1955.
PMID: 36503976
DOI: 10.1007/s00404-022-06837-1.
Expression and Signaling Pathways of Nerve Growth Factor (NGF) and Pro-NGF in Breast Cancer: A Systematic Review.
Bruno F, Arcuri D, Vozzo F, Malvaso A, Montesanto A, Maletta R
Curr Oncol. 2022; 29(11):8103-8120.
PMID: 36354700
PMC: 9689427.
DOI: 10.3390/curroncol29110640.
Knockdown of CKAP2 Inhibits Proliferation, Migration, and Aggregate Formation in Aggressive Breast Cancer.
Dos Santos A, Ouellete G, Diorio C, Elowe S, Durocher F
Cancers (Basel). 2022; 14(15).
PMID: 35954424
PMC: 9367390.
DOI: 10.3390/cancers14153759.
Evaluation of Intraoperative Frozen Section Analysis with Final Histopathology Results for Sentinel Lymph Node Biopsy: Z0011 Criteria Eligible Versus Ineligible Breast Cancer Patients.
Reinhardt F, Fiedler A, Borgmeier F, Reinecke P, Esposito I, Mattes-Gyorgy K
Geburtshilfe Frauenheilkd. 2022; 82(6):610-618.
PMID: 35903717
PMC: 9315401.
DOI: 10.1055/a-1749-5226.
